ArticleGeroScience2026
Weight loss aggravates obesity-induced hypothalamic inflammation in mid-aged mice.
Article in GeroScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
While neuroinflammation is an established response to both weight gain and aging, the hypothalamic neuroinflammatory early response to weight loss (WL) remains unknown, particularly in mid-age. Here, we questioned whether WL-induced rapid restoration of normoglycemia is mediated by the resolution of hypothalamic microgliosis in mid-aged mice. Mid-aged (1 year) mice were fed normal chow (NC) or a high-fat diet (HFD, 8 weeks), and WL was induced by a 2-week switch back to NC. Key findings were compared to young (7 weeks) mice. Mid-aged WL mice lost within 2 weeks 54% of their excess body weight, somewhat less than young mice (68%). Whole-hypothalamus RNA sequencing revealed ~ 4 times more differentially expressed genes (DEGs) in mid-aged than in young mice (2419 vs. 670, respectively). Nevertheless, in both ages, WL did not reverse but rather aggravated the transcriptomic response to HFD in ~ 80% of DEGs, uncovering downregulated metabolic (oxidative phosphorylation, thermogenesis) and neurodegenerative pathways, particularly in mid-age. Consistently, in the arcuate nucleus (ARC), HFD-induced increase in microglial number and volume further increased in weight-losing mid-aged mice. Consistently, only in mid-aged mice, WL further increased HFD-induced mean single-microglial volume in ARC, corresponding to increased pNFκB-(p-p65) nuclear staining. Despite aggravated hypothalamic and microglial changes, mid-aged mice fully normalized impaired glucose tolerance by early WL. Adipose tissue inflammation was not resolved in mid-aged WL mice, and adipose tissue crown-like-structure density correlated with ARC microglial cell volume (Rho(ρ) = 0.691, p = 0.001). In conclusion, in mid-aged mice, obesity-induced hypothalamic and microglial changes were aggravated during the early response to WL. The resolution of these obesity-induced changes is not required for the normalization of glucose intolerance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.